Previous studies have shown that ERK1/2 is abundantly expressed in various human tumors, including GC, hepatocellular carcinoma, glioblastoma multiforme, breast cancer, and lung cancer [35–39]. This evidence concerns the gene MAPK3 and lung carcinoma.